In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



Set Alert for Leadership

The Clinical Trial Accessibility Checklist: How Does Your Organization Measure Up?

This year marks the 30th anniversary of the NIH revitalization act that required women and minorities to be included in clinical research in the US. Putting that into perspective, we have only really been collecting data at scale on women and minorities since the movie Jurassic Park was launched. If we want more people to participate in clinical trials, it is time to get real about reducing the burden of research on volunteers.

Clinical Trials Diversity & Inclusion

Execs On The Move: August 2023

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Commercial Executive Changes

Insitro’s Daphne Koller On The Marriage Of Biology And Machine Learning At The Company’s Heart

Industry veteran and serial entrepreneur Daphne Koller tells In Vivo about how her company, Insitro, is unleashing the potential of computational biology and machine learning to discover new drug compounds.

Innovation Artificial Intelligence

Boehringer’s Innovation Strategy Does Not Avoid Areas With Heavy Competition

BI’s global head of innovation Michel Pairet tells In Vivo that while unmet medical need is the pharma’s R&D priority, its main focus is bringing breakthrough therapy potential to patients, and it is taking aim at competitive spaces like metabolic health and cancer.

Business Strategies Leadership

A Next-Gen Approach To Health Care Risk And Compliance

Across the health care industry, the increasing numbers of ethics violations, data breaches and reputational challenges reflect the growing magnitude and prevalence of compliance failures.

Commercial Strategies Business Strategies

Podcast: Creating A Digital Biotech Story

In this latest instalment of the In Vivo podcast Daniel Lofaso, CEO of Digital Elevator, talks about the common mistakes biotech companies make when trying to build their brand, how to connect with varied audiences and key trends the industry should keep track of in digital marketing.

Business Strategies StartUps and SMEs

Exploring Alltrna’s Rare Disease Platform

Michelle Werner, CEO of Alltrna, sat down with In Vivo to discuss rare disease as an increasingly important area of study, innovation in the space and how the emerging biotech hopes to impact the treatment landscape.

Rare Diseases Rising Leaders

AI Driving Innovation: Insights From Exscientia CEO Andrew Hopkins

Andrew Hopkins, founder and CEO of Exscientia, invented and championed an algorithmic approach to drug design and drug discovery. He talks to In Vivo about artificial intelligence in the biopharma industry today and what lies ahead. 

Artificial Intelligence Clinical Trials

20 Years After First FDA Filing, Gepirone Finally Approaches Depression Market

Private drug developer Fabre-Kramer is expecting approval for its antidepressant gepirone hydrochloride in September 2023. The drug has been rejected multiple times by the FDA as a treatment for major depressive disorder. 

Neurology Approvals

Titans Of Pharma: Pfizer’s Bourla Tops Big Pharma CEO Compensation League

Infographic: A snapshot of executive compensation at the world’s biggest pharmaceutical companies. Explore our interactive dashboard and visualizations comparing remuneration packages with other key company metrics.

Leadership Sales & Earnings

A Day Job And A Gay Job: How OUTbio Is Connecting LGBTQ Biotech Executives

LGBTQ networking group OUTbio has gone from strength to strength since it was founded in 2015, from a small event attended by a handful of executives in Boston to a registered non-profit with affiliated groups across the US alongside international branches.

Leadership Diversity & Inclusion

Execs On The Move: July 2023

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Medical Device BioPharmaceutical

Rethinking Commercialization Models In The Age Of Pricing And Access Complexity

In an environment replete with pricing and patient access pressures, top biopharma companies are building commercialization models that emphasize inclusive and diverse decision-making and that integrate digital tools with a human salesforce.

Commercial Innovation

J&J Leans Into The Patient Opportunity In Vision

Jacqueline Henderson was appointed president, Johnson & Johnson Vision, EMEA, in April, as part of a restructuring of senior regional roles. Now overseeing this most culturally diverse of territories for both Vision Care and Surgical Vision, she explains the rationale for the internal realignment and where Johnson & Johnson Vision goes next.

Leadership Ophthalmology

Marinus On Track To Be Leader In Rare Epilepsy Market, Says CEO

CEO Scott Braunstein, who took leadership of Marinus in 2019 following clinical trial setbacks, believes the company is on a route to success with its ganaxolone program, targeting chronic use and hospital markets. 

Neurology Research & Development

AI Medical Technology: The Trials, Tribulations And Motivations Behind A Start-Up

Christoffer Ekström, one of In Vivo's 2023 Rising Leaders, spoke about the challenges a start-up founder faces, the importance of never giving up and how one should always learn from the past.

Medical Device Rising Leaders
See All